Home Sirtex Medical

Sirtex Medical

In operation
-
Targeted Radiotherapy Developer for Liver Tumors

Basic Information

Sirtex Medical is a global healthcare company with offices in the United States, Australia, Germany, and Singapore, dedicated to improving treatment outcomes for cancer patients. Our current leading product is a liver tumor-targeted radiation therapy called SIR-Spheres® Y-90 Resin Microspheres. More than 100,000 doses have been supplied to over 1,300 medical centers in more than 50 countries for the treatment of liver cancer patients.
Sirtex SIR-Spheres Pty Ltd
Sydney,NewSouthWales,Australia
101~500 people
January 01, 1997
info-au@sirtex.com